Baird Medical Investment Holdings Limited Research and Development Expense
Baird Medical Investment Holdings Limited (BDMD) reported Research and Development Expense of $20.13 million for the 12-month period ending 2025-12-31, per its 20-F/A filed 2026-07-27.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2026-07-27
| Period end | Research and Development Expense 6 month | Research and Development Expense 12 month |
|---|---|---|
| 2025-12-31 | $20.13M 20-F/A · filed 2026-07-27 | |
| 2025-06-30 | $7.18M 6-K · filed 2025-12-05 | |
| 2024-12-31 | $6.17M 20-F/A · filed 2026-07-27 | |
| 2024-06-30 | $2.03M 6-K · filed 2025-12-05 | |
| 2023-12-31 | $4.27M 20-F/A · filed 2026-07-27 | |
| 2022-12-31 | $3.86M 20-F · filed 2025-05-15 |